Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Nursing Perspectives
Video Expert Opinion
Sign in
Join now
featured
Published in Metastatic Breast Cancer

Expert Opinion / Cases · October 30, 2020

Chemotherapy or Only Endocrine Therapy?

Ana Sandoval Leon MD

 

 Save  Recommend
 Share

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • mehrdad payadeh

    Oct 31, 2020

    Chemotherapy due to high Ki67

  • Bogdan Cristian Dinu

    Oct 31, 2020

    Chemo based by PgR level , LVI and Ki67

  • luis betancourt

    Oct 31, 2020

    Chemotherapy. Radiotherapy?

  • [email protected] [email protected]

    Nov 01, 2020

    Chemotherapy should be recommended. The benefit and potential hazard should be fully discussed with the patient, based on her high Ki67, LVI, relatively young age. Besides, information related to tumor grade and menopausal status should be provided for detailed discussion.

  • giovanni marini

    Nov 01, 2020

    chemioterapia seguita da ormonoterapia (Google translate: chemotherapy followed by hormonal therapy)

  • Kendra Dean

    Nov 02, 2020

    Chemo due to age, male and Ki67

  • neil lins

    Nov 06, 2020

    QT + HT

  • Raphael Catane

    Nov 06, 2020

    Why performing Oncotype, if you don't follow its recommendation.

  • Serkan Akin

    Nov 06, 2020

    Ki67 of final path report should be considered. Oncotype score could also be reliable in males. However I think the most necessary issue should be to check BRCA and other germline mutations in this guy. Eventually I want to start him tamoxifen for 5 years with close follow-up

  • JULIO CESAR VELASCO RODRIGUEZ

    Nov 07, 2020

    oncotype in male breast cancer is rarely used, but it serves to avoid over-treating patients, experience is limited, but would only indicate hormonal therapy based on the oncotype score

  • Sewa Legha

    Nov 07, 2020

    Male Breast Cancer is highly sensitive to Hormonal therapy. So it is generally the preferred first option of treatment.
In addition to endocrine therapy, a case can be made to adding chemotherapy to high risk patients(such as those with Lymph node metastases.
Since this patient has node negative disease, I would not recommend any chemotherapy. Instead use endocrine therapy such as Tamoxifen for a duration of 5 years.
Sewa S. Legha, MD

  • Del Barco Sonia

    Nov 09, 2020

    First, if you do oncotype .. you follow it or not?
Second, in case of woman i choose chemo because age and therefore in this case, the same

  • Ludwing Bacon Fonseca

    Dec 11, 2020

    If I send a Genomic profile.... I should follow the recommendation.... so my personal opinion with all information is : Tamoxifen x 5a

  • Jan 22, 2025

    Pending Moderator approval.
    Delete

Further Reading

Most Read This Week

Recently Updated